Please login to the form below

Not currently logged in
Email:
Password:

William Humphries joins board of Clearside Biomedical

New CEO of Merz Pharma’s US operations joins the eyecare firm's board

Clearside Biomedical has appointed CEO of Merz Pharma's North American operations, William Humphries, to its board of directors.

Humphries joins the US-based firm, which specialises in developing eyecare products, just two weeks after his appointment at Merz Inc.

Clearside will be keen to make use of Humphries' 25 years' experience in the pharma industry as it looks to develop its microinjection platform to develop therapeutics for sight threatening conditions such as macular oedema and vascular leakage.

Prior to his appointment at Merz, Humphries was president of the GlaxoSmithKline company Stiefel, which specialises in dermatology.

Humphries has also held senior executive roles at Allergan, including VP of its US skincare business.

"Having served under Bill at Stiefel, I know firsthand how talented he is in the global commercialisation of products in today's healthcare environment and his experience is already providing an important impact to Clearside Biomedical," said Daniel White, Clearside's president and CEO.

"Bill brings a complementary vision to our company and a wealth of knowledge to the table that will help guide our company to achieving its goal of providing valuable medical solutions for patients suffering from sight-threatening illness."

4th April 2012

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...
Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...